Regenerx Biopharmaceuticals, Inc. (AMEX: RGN) announced today that National Institutes of Health (NIH) has awarded 12 research grants totaling over ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE